The PDE1A gene helps cells switch off chemical signals called cAMP and cGMP, which support how blood vessels, the heart, and other tissues work. If this gene does not work properly, those signals can stay active too long and disrupt normal control of vessel tone and cell growth. Some variants in the PDE1A gene are linked to differences in blood pressure and, in some families, to changes in the aorta, the body’s main artery. Understanding this gene can help make sense of how your body regulates blood flow.
What is a gene?
A gene is a piece of DNA that carries instructions your cells use to make molecules or to regulate processes throughout the body. Some genes provide the directions for producing proteins, which are the parts of cells that do much of the work. Others mainly guide when specific processes happen, where they happen, and how active they are. In combination, genes affect how the body grows and works, and they can also influence how you respond to food, stress, or medicines. For a deeper look at this topic, you can find more in LearnHub.
Overview
PDE1AGene function
What if the gene works
The PDE1A gene helps cells break down cAMP and cGMP, two messenger molecules. This supports signaling in the heart, blood vessels, brain, and other tissues.
Risk
What if the gene does not work
Changes in the PDE1A gene can reduce or disrupt breakdown of cell messenger molecules called cAMP and cGMP. Milder variants may partly weaken this control, while more severe variants can cause loss of signaling controlled by calcium inside cells.
Treatment
What does that mean for your treatment
No PDE1A-specific treatment or management approach is currently established. The PDE1A gene is being studied as a possible drug target in some heart and blood vessel conditions, but this has not changed treatment choices in current clinical guidelines for people with PDE1A variants.
Gene function
What if the gene works
Cells use the PDE1A gene to keep internal messages from lasting too long. It makes an enzyme that clears two common signaling molecules, cAMP and cGMP, after they have carried their message. This helps explain what the PDE1A gene does in the body every day: it keeps cell responses measured and well timed.
The PDE1A gene helps cells break down cAMP and cGMP, two small messenger molecules used for cell signaling. Clearing these signals at the right time keeps messages from lingering longer than needed.
Its enzyme becomes more active when calcium rises and binds calmodulin (a protein that senses calcium). This lets cells connect calcium changes with control of cAMP and cGMP.
By adjusting how much cAMP and cGMP remain in a cell, the PDE1A gene helps set the strength and length of normal signals. That supports measured communication across many tissues.
What is a variant?
A genetic variant is a small difference in the DNA sequence of a gene. These changes are common and help shape normal human diversity, including differences in appearance, metabolism, or how the body responds to environmental influences. Many variants do not have any noticeable effect and simply represent natural genetic variation. In some cases, though, a variant can change how a gene works more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Changes in the PDE1A gene can alter how much PDE1A protein a cell makes, how stable it is, or how well it responds to calcium linked control signals. In practical terms, how variants influence the PDE1A gene's function often comes down to reduced ability to break down cAMP and cGMP, chemical signals inside cells. Milder variants may partly lower activity or change regulation, while more severe variants can greatly reduce or stop enzyme activity altogether.
How variants are linked to conditions
Pathogenic variants in the PDE1A gene are linked to familial thoracic aortic aneurysm and dissection, an inherited condition affecting the body’s main artery. In families with a PDE1A gene variant linked to thoracic aortic aneurysm and dissection, the aorta may widen over time and can sometimes develop a tear. Age at diagnosis and the severity of aortic disease can vary from person to person.
A variant is not necessarily a diagnosis
Genetic variants are common across the general population and are a usual part of human biology. Most do not directly affect health and simply contribute to normal human diversity. For many genes, having a variant associated with a condition points to a possible link rather than a certain diagnosis, particularly when several genes and environmental influences play a role. In some situations, though, one well-characterized variant in a particular gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There isn't yet broadly confirmed evidence on specific factors that increase or reduce risk related to the PDE1A gene. Anyone with concerns about a PDE1A result or their personal risk should speak with a doctor or genetic counselor.
Inheritance of PDE1A variants
There is not yet a broadly confirmed, disease-specific Mendelian pattern for how PDE1A gene variants are inherited, although this can become clearer as research develops. In other words, the answer to how PDE1A gene variants are inherited is still being defined for any confirmed PDE1A related condition. The PDE1A gene is located on chromosome 2, which is an autosome. That means each person inherits one copy of the PDE1A gene from each parent.
What does my PDE1A result mean for my family?
For PDE1A, the best-known family pattern is dominant, which means a gene change can run through several generations. Close relatives such as parents, brothers, sisters, and children may also carry the same change, so the result can matter for the wider family, not just one person. In families with a PDE1A change linked to aortic disease, first-degree relatives are often the main relatives considered for family testing.
Genetic information
Genetic testing
How you find out about variants
PDE1A genetic testing looks for changes in the PDE1A gene using a blood sample, saliva, or a cheek swab. A lab reads the gene’s DNA code and checks for variants that may help explain a health condition or family history. Results usually classify a finding as benign, uncertain, or linked to disease.
When should I consider getting a genetic test?
Consider testing for changes in the PDE1A gene if you or close relatives have had unexplained widening or tearing of the body’s main artery, called the aorta, especially at a young age. It may also be worth discussing if thoracic aortic aneurysm seems to run in your family.
A genetic result is only one part of your health story
Genetic test results can provide useful insight, but the amount they reveal depends on the condition and the specific type of variant. Over time, the way the body functions is shaped by many factors, including lifestyle, environment, age, and medical history. In some conditions, particularly those affected by many genes, genetic information offers context rather than certainty and makes the most sense when considered with other parts of care. In other situations, a genetic result can give a clear answer. For areas like medication response, genetic results may also help put personal experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in genes can change how the body breaks down a drug, moves it through the body, or responds to it at its target. This helps explain why the same medication may work well for one person, have less effect in another, or cause more side effects in someone else.
What is Pharmacogenetics?
Pharmacogenetics examines how differences in a person’s genes affect the way they respond to medicines. It studies gene drug patterns to better explain why the same treatment can work differently in different people. For many drugs, genes influence both how strong a medicine’s effects are and how the body processes it. This information can support treatment decisions that are more informed and more individualized. More detail on this topic is available in the LearnHub.
Drugs influenced by the PDE1A gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication choices, so if you have side effects, your treatment is not working as expected, or you are starting a new medicine, it is best to discuss this with your doctor.
History
PDE1A entered genetics through broader work on phosphodiesterases, a family of genes studied for their role in cell signaling. In recent decades, awareness of this gene’s role has grown as researchers separated closely related phosphodiesterase genes and mapped where PDE1A is active in the body. Building on this early work, scientists cloned the PDE1A gene and described different forms made from the same gene in human tissues. Later studies connected PDE1A to blood vessel biology and kidney research, which helped move it from a basic science finding into medical genetics. Over time, descriptions became more precise as laboratory tools improved and the PDE1A gene was placed more clearly within the larger phosphodiesterase family.